The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CNO's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in of 310 cases, the price rose further within the following month. The odds of a continued upward trend are .
CNO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 301 cases where CNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on December 06, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CNO as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CNO turned negative on November 29, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
CNO moved below its 50-day moving average on December 18, 2024 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.334) is normal, around the industry mean (1.496). P/E Ratio (11.333) is within average values for comparable stocks, (39.438). CNO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.675). Dividend Yield (0.022) settles around the average of (0.140) among similar stocks. P/S Ratio (0.755) is also within normal values, averaging (2.172).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a provider of health and life insurance services
Industry LifeHealthInsurance
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IFAFX | 24.28 | 0.19 | +0.79% |
American Funds Income Fund of Amer F1 | |||
SIIEX | 14.40 | 0.06 | +0.42% |
Touchstone International Value Y | |||
PGROX | 66.21 | 0.14 | +0.21% |
BNY Mellon Worldwide Growth A | |||
GQJIX | 9.83 | -0.10 | -1.01% |
GQG Partners Intl Qual Val Fd Ins | |||
FLCKX | 38.90 | -0.54 | -1.37% |
Fidelity Leveraged Company Stock K |
A.I.dvisor indicates that over the last year, CNO has been closely correlated with PRU. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNO jumps, then PRU could also see price increases.